Understanding how TRIP13 contributes to radiation resistance in oral cancer
Elucidating the Molecular Mechanism of TRIP13-mediated Radiation Resistance in Oral Squamous Cell Carcinoma
This study is looking at a protein called TRIP13 that helps some oral cancer cells survive radiation treatment, and by understanding how it works, the researchers hope to find ways to make these tumors more responsive to radiation, which could lead to better treatment options for patients.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11080749 on NIH RePORTER |
What this research studies
This research investigates the role of TRIP13, a protein that helps cancer cells repair damage caused by radiation, in oral squamous cell carcinoma (OSCC). By exploring the molecular mechanisms behind TRIP13's function, the study aims to uncover why some tumors resist radiation treatment, which is a common therapy for OSCC. The researchers will focus on how TRIP13 interacts with DNA repair processes, particularly the non-homologous end joining pathway, to enhance the survival of cancer cells after radiation exposure. This understanding could lead to new strategies that make tumors more sensitive to radiation, potentially improving treatment outcomes for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with oral squamous cell carcinoma who are undergoing radiation therapy.
Not a fit: Patients with other types of cancers or those not receiving radiation therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved radiation therapies for patients with oral squamous cell carcinoma, enhancing treatment effectiveness and reducing tumor recurrence.
How similar studies have performed: Previous research has shown that targeting DNA repair mechanisms can enhance the effectiveness of radiation therapy, suggesting that this approach may yield promising results.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Hutchinson, Marsha-Kay Norissa Deanna — University of Michigan at Ann Arbor
- Study coordinator: Hutchinson, Marsha-Kay Norissa Deanna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.